SCHEMBL9593755

SCHEMBL9593755

Cc1cc2nc3cc(C)c(C)cc3c(Nc3cccc(CO)c3)c2cc1C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 5/20 0.68
▸ TOP2B Q02880 5/20 0.68
▸ KDM1A O60341 3/20 0.48
▸ ABCG2 Q9UNQ0 3/20 0.47
▸ RAPGEF4 Q8WZA2 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ RAD52 P43351 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SYK P43405 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ JAK1 P23458 2/20 0.40
▸ JAK3 P52333 2/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ FLT1 P17948 1/20 0.40
▸ FLT4 P35916 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ CSNK2A1 P68400 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9593811 0.93 TOP2A (0.63) TOP2ATOP2BKDM1AABCG2RAPGEF4
SCHEMBL9592851 0.93 TOP2A (0.63) TOP2ATOP2BKDM1AABCG2RAPGEF4
SCHEMBL9593549 0.91 TOP2A (0.57) TOP2ATOP2BKDM1AABCG2POLB
SCHEMBL9593497 0.91 TOP2A (0.57) TOP2ATOP2BKDM1AABCG2POLB
SCHEMBL9593866 0.91 TOP2A (0.57) TOP2ATOP2BKDM1AABCG2POLB
SCHEMBL9593418 0.89 TOP2A (0.58) TOP2ATOP2BKDM1AABCG2MEN1
SCHEMBL9595379 0.89 TOP2A (0.58) TOP2ATOP2BKDM1ARAPGEF4MEN1
SCHEMBL9594484 0.85 TOP2A (0.57) TOP2ATOP2BKDM1AABCG2FLT1
SCHEMBL9593668 0.85 TOP2A (0.57) TOP2ATOP2BKDM1AABCG2FLT1
SCHEMBL9594725 0.85 TOP2A (0.71) TOP2ATOP2BKDM1AABCG2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO claimed
US-5229395-A Potential anticancer agents derived from acridine SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-07-20 — — US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO disclosed
Send feedback